Primus Pharmaceuticals, Inc.
Primus Pharmaceuticals, Inc. appears in FDA public data with 4 recalls — including 4 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0346-2018, Class I) was initiated on January 26, 2018.
Summary
- Total Recalls
- 4 (4 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0346-2018 | Class I | Limbrel250 (flavocoxid and citrated zinc bisglycinate) 250 mg/50 mg capsules, 60-count bottle, Rx o | January 26, 2018 |
| D-0345-2018 | Class I | Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuti | January 26, 2018 |
| D-0347-2018 | Class I | Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx on | January 26, 2018 |
| D-0344-2018 | Class I | Limbrel (flavocoxid 250 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuti | January 26, 2018 |